Lianhe Life is a fully integrated CDMO and CRO supporting biotech and pharma partners across discovery, preclinical, clinical and commercial-scale GMP manufacturing. Small molecules, biologics and cell & gene therapies — one team, one timeline, one quality system.
Explore Services Request a ProposalBiotech timelines are tight. We structure every engagement around a single project lead, transparent milestones and a quality system aligned with FDA, EMA and NMPA expectations.
Research, process development and GMP manufacturing in one partnership — eliminating handoffs between external vendors.
FDA, EMA, PMDA and NMPA inspection-ready facilities with a proven track record across IND, NDA and BLA filings.
From 50 mg medicinal chemistry batches to 2,000 L biologics runs — scale-up without changing partners.
Whether you're working on a small molecule, a monoclonal antibody or a cell therapy — our capabilities span the entire drug development lifecycle.
Target validation, hit-to-lead, lead optimisation, SAR studies and library synthesis. Integrated in vitro ADMET and safety screening.
Monoclonal antibodies, bispecifics, ADCs and fusion proteins. Hybridoma, phage display and humanisation platforms.
Route scouting, process characterisation, formulation development, tech transfer and scale-up to GMP manufacturing.
cGMP manufacturing for clinical supply through commercial launch. Small molecule API, biologics bulk drug substance and fill-finish.
GLP in vivo pharmacology, PK/PD, safety pharmacology and IND-enabling toxicology — AAALAC accredited facilities.
Phase I to III clinical operations across Asia-Pacific, including regulatory strategy, monitoring, biometrics and pharmacovigilance.
Every program is different — our engagement models are designed to fit yours, from virtual biotech to global top-20 pharma.
Single partner spanning chemistry, biology, DMPK and tox — IND-ready package delivered in 18–24 months.
Take your candidate from bench to first-in-human with a single CDMO — no tech-transfer risk.
Multi-site capacity for commercial API and drug product. Tech transfer, validation and ongoing supply.
Dedicated chemistry, biology and DMPK FTE teams integrated into your global R&D organisation.
Viral vector and cell therapy process development and GMP production under ATMP-aligned quality.
End-to-end Phase I–III clinical operations across China, Korea, Japan, Singapore and Australia.
We work with biotech startups, mid-sized pharma, top-20 multinationals and academic spinouts across more than 20 countries.
Tell us about your project — from early discovery to commercial manufacturing, we'll respond with a scoped proposal in days, not weeks.
Request a Proposal